ALZpath Blood Test Enables Large-Scale Alzheimer’s Disease Study
Study using pTau217 assay finds more than one in 10 adults over age 70 may be eligible for treatments to slow cognitive decline.
Read MorePosted by CLP Edit Staff | Dec 19, 2025 | Dementias & Alzheimer’s |
Study using pTau217 assay finds more than one in 10 adults over age 70 may be eligible for treatments to slow cognitive decline.
Read MorePosted by CLP Edit Staff | Dec 4, 2025 | Dementias & Alzheimer’s |
A longitudinal study finds blood-based biomarkers more sensitive than PET scans in detecting obesity’s impact on Alzheimer’s pathology.
Read MorePosted by CLP Edit Staff | Nov 7, 2025 | Cancer |
Oncoguard Liver test demonstrates seven times greater sensitivity for very early-stage hepatocellular carcinoma compared to ultrasound surveillance.
Read MorePosted by CLP Edit Staff | Oct 10, 2025 | Prenatal Testing |
Researchers urge clinicians to integrate lipid management into prenatal care to mitigate elevated obstetric complications and cardiovascular risks.
Read MorePosted by CLP Edit Staff | Sep 11, 2025 | Molecular Diagnostics |
A new AI-powered platform provides meal suggestions, ingredient substitutions, and meal planning guidance to help patients avoid their identified trigger foods.
Read More